308 related articles for article (PubMed ID: 28970115)
1. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.
Dora CP; Kushwah V; Katiyar SS; Kumar P; Pillay V; Suresh S; Jain S
Int J Pharm; 2017 Dec; 534(1-2):1-13. PubMed ID: 28970115
[TBL] [Abstract][Full Text] [Related]
2. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
3. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability.
Dora CP; Trotta F; Kushwah V; Devasari N; Singh C; Suresh S; Jain S
Carbohydr Polym; 2016 Feb; 137():339-349. PubMed ID: 26686138
[TBL] [Abstract][Full Text] [Related]
4. Preparation of ursolic acid-phospholipid complex by solvent-assisted grinding method to improve dissolution and oral bioavailability.
Wang W; Zhang W; Jiang Y; Wang X; Zhang X; Liu H; Zhang T
Pharm Dev Technol; 2020 Jan; 25(1):68-75. PubMed ID: 31544585
[TBL] [Abstract][Full Text] [Related]
5. A phospholipid complex to improve the oral bioavailability of flavonoids.
Wang H; Cui Y; Fu Q; Deng B; Li G; Yang J; Wu T; Xie Y
Drug Dev Ind Pharm; 2015; 41(10):1693-703. PubMed ID: 25496311
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
7. Novel rifampicin-phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation.
Singh C; Bhatt TD; Gill MS; Suresh S
Int J Pharm; 2014 Jan; 460(1-2):220-7. PubMed ID: 24188983
[TBL] [Abstract][Full Text] [Related]
8. Erlotinib complexation with randomly methylated
Erdoğar N; Akkın S; Varan G; Bilensoy E
Pharm Dev Technol; 2021 Sep; 26(7):797-806. PubMed ID: 34219578
[TBL] [Abstract][Full Text] [Related]
9. Preparation of a nanoscale dihydromyricetin-phospholipid complex to improve the bioavailability: in vitro and in vivo evaluations.
Zhao X; Shi C; Zhou X; Lin T; Gong Y; Yin M; Fan L; Wang W; Fang J
Eur J Pharm Sci; 2019 Oct; 138():104994. PubMed ID: 31302210
[TBL] [Abstract][Full Text] [Related]
10. Phytophospholipid Complex of Caffeic Acid: Development, In vitro Characterization, and In Vivo Investigation of Antihyperlipidemic and Hepatoprotective Action in Rats.
Mangrulkar S; Shah P; Navnage S; Mazumdar P; Chaple D
AAPS PharmSciTech; 2021 Jan; 22(1):28. PubMed ID: 33404939
[TBL] [Abstract][Full Text] [Related]
11. Erlotinib-Valproic Acid Liquisolid Formulation: Evaluating Oral Bioavailability and Cytotoxicity in Erlotinib-Resistant Non-small Cell Lung Cancer Cells.
Patel K; Doddapaneni R; Patki M; Sekar V; Bagde A; Singh M
AAPS PharmSciTech; 2019 Mar; 20(3):135. PubMed ID: 30830506
[TBL] [Abstract][Full Text] [Related]
12. Improved metabolic stability and therapeutic efficacy of a novel molecular gemcitabine phospholipid complex.
Dora CP; Kushwah V; Katiyar SS; Kumar P; Pillay V; Suresh S; Jain S
Int J Pharm; 2017 Sep; 530(1-2):113-127. PubMed ID: 28739504
[TBL] [Abstract][Full Text] [Related]
13. Phospholipid complex enriched micelles: A novel drug delivery approach for promoting the antidiabetic effect of repaglinide.
Kassem AA; Abd El-Alim SH; Basha M; Salama A
Eur J Pharm Sci; 2017 Mar; 99():75-84. PubMed ID: 27998799
[TBL] [Abstract][Full Text] [Related]
14. Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights.
Venkateskumar K; Parasuraman S; Gunasunderi R; Sureshkumar K; Nayak MM; Shah SAA; Khoo K; Kai HW
AAPS PharmSciTech; 2017 Aug; 18(6):2085-2094. PubMed ID: 28004342
[TBL] [Abstract][Full Text] [Related]
15. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
Gera S; Talluri S; Rangaraj N; Sampathi S
AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
17. Investigation of salt formation between memantine and pamoic acid: Its exploitation in nanocrystalline form as long acting injection.
Mittapelly N; Rachumallu R; Pandey G; Sharma S; Arya A; Bhatta RS; Mishra PR
Eur J Pharm Biopharm; 2016 Apr; 101():62-71. PubMed ID: 26850817
[TBL] [Abstract][Full Text] [Related]
18. Novel Self-Assembled Ibrutinib-Phospholipid Complex for Potently Peroral Delivery of Poorly Soluble Drugs with pH-Dependent Solubility.
Qiu Q; Lu M; Li C; Luo X; Liu X; Hu L; Liu M; Zheng H; Zhang H; Liu M; Lai C; Song Y; Deng Y
AAPS PharmSciTech; 2018 Nov; 19(8):3571-3583. PubMed ID: 30209789
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of kaempferol-phospholipid complex for pharmacokinetics and bioavailability in SD rats.
Zhang K; Gu L; Chen J; Zhang Y; Jiang Y; Zhao L; Bi K; Chen X
J Pharm Biomed Anal; 2015 Oct; 114():168-75. PubMed ID: 26051640
[TBL] [Abstract][Full Text] [Related]
20. A novel drug-phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivo.
Xia HJ; Zhang ZH; Jin X; Hu Q; Chen XY; Jia XB
Int J Nanomedicine; 2013; 8():545-54. PubMed ID: 23431115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
